Furthermore, Muto et al. reported that, in decompensated cirrhotic patients, the administration of branched-chain amino acids (BCAA) significantly increased albumin levels and reduced progression to hepatic failure compared with diet therapy alone [24]. The gene discussed is ALB; the disease is Hepatic failure.